Texas Senate · Jun 1, 2025
passage
Result: pass
SB 2308: Relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy and to the administration of that treatment.
State vote data last updated Oct 15, 2026, 8:06 AM.
Totals
| Yea | Nay | Not voting | |
|---|---|---|---|
| Total | 134 | 4 | 1 |
All voters
Texas published only the totals for this vote, not how each legislator voted.